Results 231 to 240 of about 60,412 (260)

RET Inhibitors in Non-Small-Cell Lung Cancer

Cancers, 2021
Vincenzo Sforza, Alessandro Morabito, Nicola Normanno   +2 more
exaly  

Selective RET kinase inhibition for patients with RET-altered cancers

Annals of Oncology, 2018
Alexander Drilon, Vivek Subbiah, V Velcheti   +2 more
exaly  

RET

2022
Bin Xu, Ronald Ghossein
openaire   +1 more source

RET/PTC Rearrangement in Thyroid Tumors

Endocrine Pathology, 2002
Yuri Nikiforov, Nikiforov Yuri E
exaly  

RET fusions in solid tumors

Cancer Treatment Reviews, 2019
Michael Mccusker, Alessandro Russo
exaly  

Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation

European Journal of Medicinal Chemistry, 2020
Naresh Gunaganti, Naga Rajiv Lakkaniga, Hong-Yu Li   +2 more
exaly  

RET INHIBITOR

2014
KODAMA TATSUSHI, SAKAMOTO HIROSHI, TSUKAGUCHI TOSHIYUKI   +2 more
openaire   +7 more sources

Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma

Laboratory Investigation, 2004
Giovanni Tallini, Smith Brian R
exaly  

ret

2021
openaire   +1 more source

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

Cancer Letters, 2013
Kiyoshi Okamoto
exaly